You don’t have permission to access “http://www.unilever.com/news/press-and-media/press-releases/2026/sharper-focus-and-disciplined-execution-driving-competitive-performance/” on this server.
Reference #18.86f01002.1770882985.273a8365
https://errors.edgesuite.net/18.86f01002.1770882985.273a8365
Today’s figures show how the UK economy is performing, using a measure called GDP – Gross Domestic Product.
GDP measures the size and health of a country’s economy by assessing how much is produced, spent and earned over a period of time.
But the measure doesn’t tell the whole story, especially important aspects of people’s living standards or how wealth is shared.
Generally, economists, politicians, and businesses prefer GDP to grow steadily – as it means people are spending more, more jobs are being created, and more tax is being paid.
If GDP shrinks for two quarters in a row, this is known as a recession, which can lead to pay freezes and job losses.
SHANGHAI, Feb. 11, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AK3280, a novel anti-fibrotic therapy for the treatment of idiopathic pulmonary fibrosis (IPF). This clearance enables ArkBio to initiate a Phase 2 proof-of-concept (PoC) clinical trial of AK3280 in the United States.
The Phase 2 study is a multi-center, randomized, partially double-blind, placebo- and active-controlled trial designed to evaluate the efficacy, safety, and pharmacokinetics of oral AK3280 in patients with IPF. Authorization to proceed with a U.S. Phase 2 study represents a significant milestone in the global clinical development of AK3280.
IPF is a progressive, irreversible, and ultimately fatal interstitial lung disease characterized by fibrotic remodeling of lung tissue that leads to respiratory failure. The median survival following diagnosis is approximately 2–5 years. Currently approved therapies, including pirfenidone, nintedanib, and nerandomilast, can slow disease progression; however, their clinical benefit remains limited and they are frequently associated with gastrointestinal adverse events such as diarrhea and nausea. These tolerability challenges contribute to poor long-term adherence in a substantial proportion of patients. There remains a significant unmet need for therapies that provide improved efficacy with enhanced safety and tolerability profiles.
AK3280 is an optimized, small-molecule, broad-spectrum anti-fibrotic agent. In a Phase 2 proof-of-concept study conducted in China, AK3280 demonstrated encouraging clinical activity, including a statistically significant, dose-dependent absolute increase from baseline in forced vital capacity (FVC) at Week 24. Improvements were also observed across additional lung function parameters, suggesting meaningful clinical benefit. Importantly, AK3280 exhibited a favorable safety and tolerability profile, with no apparent increase in the gastrointestinal adverse effects commonly associated with currently available IPF therapies.
FDA clearance of the IND marks a pivotal step in the global development of AK3280. The upcoming international Phase 2 PoC trial is expected to generate critical clinical data to support future regulatory submissions and potential commercialization in the United States and other major markets. ArkBio remains committed to advancing AK3280 globally and to delivering more effective and better-tolerated treatment options for patients living with IPF.
About ArkBio
ArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through internal innovation and strategic collaborations.
Key pipeline assets include: Ziresovir (AK0529), the first direct-acting antiviral for RSV with positive pivotal Phase 3 results; AK3280, a potentially best-in-class anti-fibrotic agent with positive Phase 2 results in idiopathic pulmonary fibrosis; AK0901, approved in China for the treatment of ADHD and currently commercialized.
ArkBio has established strategic partnerships with multinational pharmaceutical companies and leading academic institutions, including Roche, Genentech, The Scripps Research Institute, and the Institute of Microbiology of the Chinese Academy of Sciences, as well as domestic and international biotech companies and venture capital partners.
For more information, please visit: www.arkbiosciences.com
Investor Inquiries: [email protected]
SOURCE Arkbio
Samsung Electronics Australia has reclaimed its title for having best-in-class customer satisfaction across smartphone users, winning the 2026 Most Satisfied Customers Award for Smartphones from Canstar Blue, Australia’s best-known and respected comparison website.
In the lead-up to Samsung’s upcoming Galaxy Unpacked event in San Francisco for the Galaxy S series, this latest award builds on a strong history of recognition for providing unmatched customer satisfaction for Samsung’s extensive range of smartphones. An award-winning brand, Samsung recently won Canstar’s 2025 Innovation Excellence Award for its glare-free TV technology, and had previously scooped up back-to-back Canstar Most Satisfied Customers Awards for Smartphones in 2024 and 2023.
The 2026 award followed a nationwide survey of more than 1,100 Australians, which asked consumers who had purchased a brand new smartphone in the last two years to rate their satisfaction in key categories including durability, design, camera quality, battery and charging performance, user friendliness, value for money and overall satisfaction.
Eric Chou, Vice President of Mobile eXperience at Samsung Australia, said, “This latest accolade once again showcases Samsung’s commitment to driving meaningful innovation that’s shaped by real customers’ needs, and we’re proud to be honoured with this customer satisfaction award.”
“Our goal is to redefine what’s possible when it comes to mobile hardware and software, improving convenience and functionality, and making sure our whole range of products moves to match the evolving needs of Australians. In an increasingly competitive smartphone market, we’re thrilled to see that our customers are overwhelmingly happy with their experience when using a Samsung phone.”
Tara Donnelly, Canstar Blue’s Managing Editor, Utilities, added, “Samsung has won over public opinion to secure Canstar’s 2026 Most Satisfied Customers Award for Smartphones.
“Canstar’s research shows the cost of living is influencing purchasing decisions, with price the most important factor when choosing a new phone – shaping both the timing of phone upgrades and the type of device they buy.
“Australians gave Samsung strong ratings across the board, identified for offering value and with standout performance in durability and battery life – alongside its AI features that have transformed how Australians work, create and stay connected. The award gives credit to Samsung’s ability to deliver life-changing innovation while meeting consumers’ expectations for long-term value.”
2025 saw Samsung release an exciting range of new smartphones, leaning on cutting edge hardware and AI evolution with the Galaxy S series, hardware innovation with the launch of the Galaxy Z series, as well as an emphasis on boosted functionality in an accessible package with the Galaxy A series. Across the board, a blend of innovation and delivering value for customers has propelled Samsung’s recent suite of devices and set the groundwork for what is to come in 2026. The exciting next chapter begins with Galaxy Unpacked on February 26.
Generated by cloudfront (CloudFront) Request ID: _hzIcSLyCdDPRGgXgdqBTa3Ut9PRIWcExE5htT7LtbUqEZd8PkcvfA==
AMARILLO, Texas, Feb. 11, 2026 /PRNewswire/ — Fermi Inc. (d/b/a Fermi America) (Nasdaq & LSE: FRMI), operating as Fermi America™, today highlighted continued progress in its strategic partnership with Hyundai Engineering & Construction Co., Ltd. (Hyundai E&C) to help restart large-scale nuclear construction in the United States, including ongoing Front-End Engineering Design (FEED) work supporting four AP1000 units planned for Fermi America’s Project Matador, an 11-gigawatt private energy campus outside Amarillo, Texas.
Fermi America is building this partnership as part of its long-term strategy to bring proven nuclear success and global delivery capability back to America and accelerate the deployment of the reliable, large-scale baseload power needed to meet rapidly rising demand for power in America.
As part of the partnership, Fermi America participated in Hyundai E&C’s Large-Scale Nuclear Technology Seminar on Feb. 10 at The Westin Dallas Downtown. The event brought together leaders from across the U.S. construction and nuclear sectors for practical, discipline-specific sessions on what it takes to build large-scale nuclear projects in today’s market. It also provided an opportunity to engage Texas and national contractors, strengthen supply chain readiness, and align industry partners around the execution demands of next-generation nuclear development.
The seminar covered key construction disciplines and execution topics including nuclear construction standards, modular construction concepts and procedures, major mechanical installation disciplines, specialized nuclear construction works, heavy lifting, nuclear plant building systems, and workforce development and training for skilled nuclear personnel. The event drew strong participation from Texas-based construction companies and major stakeholders across the U.S. nuclear and construction sectors.
With large-scale nuclear construction in the United States largely stalled for decades, Fermi America believes Project Matador represents a critical opportunity to restart American nuclear build capability at scale.
“It’s a very short line of companies eager to do nuclear here in America,” said Toby Neugebauer, CEO and Co-Founder of Fermi America. “The list is even shorter when you consider the projects with a COL accepted for review, active NRC engagement, and a highly characterized site that are ready to break ground this year.
As in only one.
Fermi is proud to partner with Hyundai, the only global company to have successfully built 24 nuclear reactors, ten of them simultaneously, on time and on budget. Their expertise, talent, and financial commitment, together with Westinghouse AP1000s means that with DOE and DOC support, the American nuclear renaissance can restart July 4th.”
Fermi America and Hyundai E&C are currently advancing FEED activities including site layout planning, cooling system evaluations, and cost and schedule development. These efforts are intended to strengthen project readiness and support progress toward a potential engineering, procurement, and construction (EPC) pathway.
Mesut Uzman, Chief Nuclear Construction Officer of Fermi America and CEO of Fermi Nuclear LLC, delivered remarks emphasizing the urgency of accelerating major energy infrastructure deployment.
“AI-driven load growth is accelerating faster than most people realize,” said Uzman. “The next decade will be defined by those who can build power infrastructure fast enough to support AI and industrial growth. Hyundai brings the industrial scale and execution discipline needed to deliver significant energy projects like Fermi America’s Project Matador. We see this partnership with Hyundai E&C as a critical step toward rebuilding U.S. energy capacity.”
Through its partnership with Hyundai E&C, Fermi America is working to mobilize contractors, strengthen the workforce pipeline, and rebuild the nuclear supply chain required to deliver new large-scale nuclear power plants in Texas and across the United States.
Project Matador is being developed to deliver reliable baseload power at scale to support America’s fastest-growing electricity demand, including AI infrastructure, data centers, advanced manufacturing, and other critical industries.
For media inquiries:
Lexi Swearingen
[email protected]
Fermi America™ official business information
Legal Entity: Fermi Inc. (d/b/a Fermi America) (Nasdaq & LSE: FRMI)
Brand Name: Fermi America™
Address: 620 S Taylor St #301 Amarillo, TX 79101-2436
Website: https://fermiamerica.com/
About Fermi America™:
Fermi America™ (Nasdaq & LSE: FRMI) develops next-generation private electric grids that deliver highly redundant power at gigawatt scale to support next-generation intelligence and AI compute. Co-founded by former U.S. Energy Secretary Rick Perry, and Co-Founder and former Co-Managing Partner of Quantum Energy, Toby Neugebauer, Fermi America™ combines cutting-edge technology with a deep bench of proven world-class multi-disciplinary leaders with a combined 25 GW of experience, to create the world’s largest, 11 GW next-gen private grid, helping ensure America’s energy and AI dominance. The behind-the-meter Project Matador campus is expected to integrate the nation’s biggest combined-cycle natural gas project, one of the largest clean, new nuclear power complexes in America, utility grid power, solar power, and battery energy storage, to support hyperscale AI and advanced computing.
About the Texas Tech University System
Established in 1996, the Texas Tech University System is one of the top public university systems in the nation, consisting of five universities – Texas Tech University, Texas Tech University Health Sciences Center, Angelo State University, Texas Tech University Health Sciences Center El Paso and Midwestern State University.
Headquartered in Lubbock, Texas, the TTU System is a more than $3 billion enterprise focused on advancing higher education, health care, research and outreach with approximately 21,000 employees and 64,000 students, more than 400,000 alums, a statewide economic impact of $19.2 billion and an endowment valued at $3 billion. In its short history, the TTU System has grown tremendously and is nationally acclaimed, operating at 20 academic locations in 16 cities (15 in Texas, 1 international).
In addition, the TTU System is one of only nine in the nation to offer programs for undergraduate, medical, law, nursing, pharmacy, dental and veterinary education among other academic areas.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our strategy, future operations, financial position, prospects, plans and objectives of management. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “will be,” “will likely result,” “should,” “expects,” “plans,” “anticipates,” “could,” “would,” “foresees,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “outlook,” or “continue” or the negative of these words or other similar terms or expressions. These forward-looking statements are not guarantees of future performance, but are based on management’s current expectations, assumptions, and beliefs concerning future developments and their potential effect on us, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Our expectations expressed or implied in these forward-looking statements may not turn out to be correct. Our results could be materially different from our expectations because of various risks.
SOURCE Fermi America
(Bloomberg) — Asian equities advanced for a fifth day, stretching their lead over US peers this year as relatively cheaper valuations and firmer growth prospects lured buyers. Treasuries extended their losses after stronger US jobs data.
The MSCI Asia Pacific Index rose as much as 0.8% to a record. The gauge is up around 13% so far this year, its best start to the year relative to the S&P 500 this century. South Korea’s benchmark extended its lead as the world’s best-performing market this year, while Japanese shares advanced after returning from a holiday.
Treasuries fell with the yield on the 10-year bond rising to 4.18% as traders pared bets on interest-rate cuts by the Federal Reserve this year following the jobs numbers. Money markets priced in the Fed’s next cut in July, from June previously, after the US economy added 130,000 roles in January, twice the median forecast.
In what is shaping up to be another blockbuster year, Asia’s markets are outpacing peers in the US and Europe, drawing global investors who have gradually unwound some of their dollar exposures. Investors are positioning for beneficiaries of the artificial-intelligence boom as companies channel billions of dollars into the technology, reshaping and disrupting multiple industries.
“That is what 2026 will be about: diversification across regions but also across sectors,” Elfreda Jonker, client portfolio manager at Alphinity Investment Management, said in an interview on Bloomberg Television.
That said, much of the focus on Wednesday was on the US jobs data, which indicated strength in the US economy.
The next key hurdle for markets is Friday’s US inflation report, which could reinforce the case for keeping rates higher for longer if price pressures fail to ease.
“The report will ease concerns around the consumer,” wrote Krishna Guha at Evercore, referring to US jobs data. “It pours cold water on the idea the Fed could cut rates again before mid-year and will fuel internal debate as to how restrictive policy is and how much slack there is in the labor market.”
The S&P 500 ended Wednesday flat after a bumpy session with real estate services stocks getting hit. The gauge trades at a forward price-to-earnings ratio of about 22 times, compared with about 15 times for the MSCI Asia Pacific Index.
Asia’s strength stands out when investors’ convictions in everything from tech stocks to precious metals and cryptocurrencies are being tested by shifting expectations for US interest rates and uncertainty over AI-driven disruption.
Asia is winning favor with investors as the global tech race is shifting from AI pioneers to the enablers of large-scale adoption. Regional firms control critical choke points — from advanced chips and memory to foundry services and assembly — supplying much of the hardware underpinning the AI build-out.
Read: Booming Asian Markets Widen Their Lead Over US and Europe
In other corners of the market, gold and silver edged lower, while Bitcoin declined to trade around $67,000. The dollar held its losses, benefiting the yen, which touched a two-week high.
What Bloomberg’s Strategists Say…
Even with USD/JPY well below recent highs, Tokyo clearly isn’t comfortable letting the market run unchecked. The emphasis on coordination with Washington ups the ante, reviving the threat of rate checks or other jawboning tactics to lean against renewed yen weakness.
– Mark Cranfield, Markets Live strategist. For more analysis, read here.
In commodities, oil rose as tensions in the Middle East outweighed concerns that there’s a supply glut growing. Nickel extended gains after Indonesia signaled a sharp cut to output this year, curbing supply from the world’s biggest mine.
Elsewhere, the Canadian dollar was little changed after the Republican-led US House passed legislation aimed at ending President Donald Trump’s tariffs on Canada.
Corporate Highlights:
Apple Inc.’s long-planned upgrade to the Siri virtual assistant has run into snags during testing in recent weeks, potentially pushing back the release of several highly anticipated functions. Cisco Systems Inc. gave a weaker-than-expected forecast for profitability in the current quarter, spurring concerns that mounting memory-chip prices are taking a toll on the company. McDonald’s Corp.’s US sales grew at the fastest pace in more than two years in the fourth quarter as value meals continued to resonate with cost-conscious diners. Grab Holdings Ltd. predicted full-year revenue that trailed estimates, a sign of strain in a Southeast Asian ride-hailing and food-delivery market pressured by weaker consumer sentiment. Some of the main moves in markets:
Stocks
S&P 500 futures were little changed as of 10:07 a.m. Tokyo time Hang Seng futures were little changed Nikkei 225 futures (OSE) rose 0.6% Japan’s Topix rose 0.8% Australia’s S&P/ASX 200 rose 0.6% Euro Stoxx 50 futures rose 0.6% Currencies
The Bloomberg Dollar Spot Index was little changed The euro was little changed at $1.1875 The Japanese yen rose 0.1% to 153.09 per dollar The offshore yuan rose 0.1% to 6.9024 per dollar The Australian dollar was little changed at $0.7133 Cryptocurrencies
Bitcoin fell 0.3% to $67,532.29 Ether fell 0.2% to $1,965.88 Bonds
The yield on 10-year Treasuries advanced one basis point to 4.18% Japan’s 10-year yield declined 3.5 basis points to 2.200% Australia’s 10-year yield advanced five basis points to 4.81% Commodities
West Texas Intermediate crude rose 0.5% to $64.97 a barrel Spot gold fell 0.6% to $5,053.19 an ounce This story was produced with the assistance of Bloomberg Automation.
–With assistance from Paul Dobson and Winnie Hsu.
©2026 Bloomberg L.P.
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945
TORONTO, Feb. 11, 2026 /CNW/ – Manulife Financial Corporation has filed its 2025 audited annual financial statements for the year ended December 31, 2025 and related MD&A with securities regulators, including with the Canadian Securities Administrators and with the U.S. Securities and Exchange Commission on Form 40-F. This information is available on the Company’s website at manulife.com/en/investors/results-and-reports. Shareholders may also request a hard copy of this information free of charge through the Company’s website.
About Manulife
Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as ‘MFC’ on the Toronto, New York, and the Philippine stock exchanges, and under ‘945’ in Hong Kong.
Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.
Media Contact
Fiona McLean
Manulife
437-441-7491
[email protected]
Investor Relations:
Derek Theobalds
Manulife
416-254-1774
[email protected]
SOURCE Manulife Financial Corporation
The Australian Securities and Investment Commission (ASIC) made the changes in response to concerns about the public availability of directors’ personal information on its business registers, which included the officeholder’s residential address. ASIC has removed these details from current and historical company details available through searches purchased from its website.
Joni Henry, an expert in corporate law at Pinsent Masons, said: “These long sought-after changes were made to protect the privacy and personal safety of directors and other registered officeholders. This information can be readily found and used for potential fraud or doxxing, which then creates a real-world risk of harassment and physical danger.”
“This sensible change brings Australia into line with other jurisdictions. Residential addresses of directors are not publicly available in the UK and New Zealand passed laws late last year to allow directors to have their residential addresses redacted from the publicly searchable Companies Register due to similar safety and privacy concerns,” she said.
“ASIC will still collect personal information from directors, including their address details, and require directors to update their details with ASIC and continue to hold director identification numbers. The Treasury is also proposing draft legislation to strengthen its ability to monitor and enforce compliance with these identification and registration requirements.”
Treasurer Jim Chalmers reportedly intervened to urge the removal of residential addresses from public databases, following advice from the Australian Security Intelligence Agency.
Law enforcement, regulators and government agencies, such as the Australian Taxation Office, can still access residential addresses included on ASIC’s registers.
Hannah Griffiths, an expert in insolvency at Pinsent Masons, said: “These changes will create potential challenges for insolvency practitioners. In the meantime, ASIC has agreed to provide the required information in response to direct requests made by insolvency practitioners on court appointed liquidation.”
“Other appointment types should obtain the relevant information from the directors following discussions. Names of officeholders and other details are still available on the publicly searchable company register,” she said.
“This change will likely pose a very real and practical impediment to the timely administration of a corporate insolvency by insolvency practitioners and also have the undesirable consequence of delaying the pursuit of recovery actions, enforcement of guarantees and identification of assets in corporate insolvency which will likely pose significant, and unintended, commercial risks for businesses, creditors and financiers that have historically relied on ASIC published data in respect of the whereabouts of officeholders.”
“Businesses, creditors and financiers should consider ensuring performance obligations in their contractual arrangements with counterparties to enhance identity verification of officeholders, maintain and update address for service details, and ensure adequate security is obtained at the time of entering credit facilities or trading accounts with corporate entities to insulate against this regulatory change.”